Back

Modeling the Individual Risk of Thrombosis in Oncology (MIRTO).

28 August 2017 (15:40 - 15:50)
Organised by:
Congress Presentation Part of: ESC Grants for Medical Research Innovation Thrombosis and coagulation ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Jose Manuel Soria Fernandez

Sant Pau (Spain)

4 More presentations in this session

Presentation thumbnail
The importance of type of antithrombotic treatment after aortic valve replacement for the risk of future thromboembolic and bleeding events in aortic stenosis - Comparison of mechanical -, bio prosthetic and trans-catheter (TAVI) aortic valve replacement.
Professor C. Christersson (Uppsala, SE)
Slides Video
Presentation thumbnail
Dual approach cardiac MRI for molecular assessment and interventional treatment of vulnerable coronary plaques in a porcine model.
Professor T. Heidt (Buhl, DE)
Slides Video
Presentation thumbnail
Systemic versus site targeted treatment of neoatherosclerosis.
Doctor M. Joner (Munich, DE)
Slides Video
Presentation thumbnail
Identification of mirRNA profiles associated with venous thromboembolism and recurrent events (IMPROVEMENTS).
Doctor D. Tregouet (Paris, FR)
Slides Video

Access the full session

Session thumbnail
ESC Grants for Medical Research Innovation

The Event

Event poster

ESC Congress 2017

28 August 2017 15:40 CET
You may be interested in
thumbnail
Congress Presentation
Primary venous thromboembolism prevention strategies
21 June 2025
thumbnail
Congress Presentation
31 August 2019
thumbnail
Congress Presentation
Effectiveness and safety of apixaban, low-molecular weight heparin, and warfarin among high-risk subgroups of venous thromboembolism patients with active cancer
28 August 2020
thumbnail
Congress Session
Don’t forget to look right
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources